Vaxcyte
PCVX
$93.24
Share price
-1.85%
Change (1 day)
1.13%
Change (1 year)
Categories
Vaxcyte (PCVX) - Cash on Hand
Cash on Hand as of December 2024 : S$2.34 Billion
According to Vaxcyte
's latest financial reports the company has S$2.34 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vaxcyte - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | S$2.37 B | 66.47% |
| 2023-12-31 | S$1.42 B | 14.26% |
| 2022-12-31 | S$1.24 B | 275.49% |
| 2021-12-31 | S$0.33 B | -34.92% |
| 2020-12-31 | S$0.51 B | 542.58% |
| 2019-12-31 | S$79.51 M | -11.94% |
| 2018-12-31 | S$90.28 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | S$0.34 B | -85.35% | 🇺🇸 USA |